Table 2 Second Primary Malignancy type
From: Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies
SPM | N = 21 (%) |
|---|---|
Skin cancers | 11 (52) |
Squamous cell carcinoma | 8 (38) |
Basal cell carcinoma | 2 (10) |
Undifferentiated skin cancer | 1 (5) |
Hematologic malignancies | 7 (33) |
Myelodysplastic syndrome | 4 (19) |
Acute myeloid leukemia | 2 (10) |
Plasmacytoma | 1 (5) |
Solid tumors | 3 (14) |
Bladder cancer | 1 (5) |
Prostate cancer | 1 (5) |
Breast cancer | 1 (5) |